Immutep Statistics
Total Valuation
Immutep has a market cap or net worth of $411.60 million. The enterprise value is $321.04 million.
Important Dates
The next estimated earnings date is Sunday, February 22, 2026, before market open.
| Earnings Date | Feb 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Immutep has 1.47 billion shares outstanding. The number of shares has increased by 21.21% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.47B |
| Shares Change (YoY) | +21.21% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | 2.68% |
| Owned by Institutions (%) | 48.52% |
| Float | 1.23B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 124.47 |
| Forward PS | 17.49 |
| PB Ratio | 4.37 |
| P/TBV Ratio | 4.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 97.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.69, with a Debt / Equity ratio of 0.01.
| Current Ratio | 11.69 |
| Quick Ratio | 11.02 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,753.34 |
Financial Efficiency
Return on equity (ROE) is -36.88% and return on invested capital (ROIC) is -24.16%.
| Return on Equity (ROE) | -36.88% |
| Return on Assets (ROA) | -22.66% |
| Return on Invested Capital (ROIC) | -24.16% |
| Return on Capital Employed (ROCE) | -45.08% |
| Weighted Average Cost of Capital (WACC) | 13.53% |
| Revenue Per Employee | $106,669 |
| Profits Per Employee | -$1.30M |
| Employee Count | 31 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.12% in the last 52 weeks. The beta is 1.69, so Immutep's price volatility has been higher than the market average.
| Beta (5Y) | 1.69 |
| 52-Week Price Change | +38.12% |
| 50-Day Moving Average | 2.84 |
| 200-Day Moving Average | 2.06 |
| Relative Strength Index (RSI) | 49.50 |
| Average Volume (20 Days) | 165,144 |
Short Selling Information
| Short Interest | 4.64M |
| Short Previous Month | 4.74M |
| Short % of Shares Out | 3.24% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 23.77 |
Income Statement
In the last 12 months, Immutep had revenue of $3.31 million and -$40.28 million in losses. Loss per share was -$0.03.
| Revenue | 3.31M |
| Gross Profit | -36.95M |
| Operating Income | -42.62M |
| Pretax Income | -40.28M |
| Net Income | -40.28M |
| EBITDA | -41.22M |
| EBIT | -42.62M |
| Loss Per Share | -$0.03 |
Full Income StatementBalance Sheet
The company has $85.03 million in cash and $1.07 million in debt, with a net cash position of $83.96 million or $0.06 per share.
| Cash & Cash Equivalents | 85.03M |
| Total Debt | 1.07M |
| Net Cash | 83.96M |
| Net Cash Per Share | $0.06 |
| Equity (Book Value) | 94.17M |
| Book Value Per Share | 0.06 |
| Working Capital | 89.38M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$40.68 million and capital expenditures -$30,007, giving a free cash flow of -$43.96 million.
| Operating Cash Flow | -40.68M |
| Capital Expenditures | -30,007 |
| Free Cash Flow | -43.96M |
| FCF Per Share | -$0.03 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,288.94% |
| Pretax Margin | -1,218.02% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Immutep does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.21% |
| Shareholder Yield | -21.21% |
| Earnings Yield | -9.79% |
| FCF Yield | -10.68% |
Analyst Forecast
The average price target for Immutep is $6.00, which is 115.05% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.00 |
| Price Target Difference | 115.05% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 135.11% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 28, 2016. It was a reverse split with a ratio of 1:3.33.
| Last Split Date | Dec 28, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:3.33 |
Scores
Immutep has an Altman Z-Score of 16 and a Piotroski F-Score of 1.
| Altman Z-Score | 16 |
| Piotroski F-Score | 1 |
